Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
Anorexia Nervosa (AN) is a serious illness associated with substantial morbidity and
mortality. Weight restoration is a treatment priority, and better treatments are needed.
Phase:
N/A
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborators:
Johns Hopkins University National Institute of Mental Health (NIMH) University of Pittsburgh University of Toronto Weill Medical College of Cornell University